Suvretta Capital Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $92.5M | Sell |
|
|||||
|
2024
Q4 | $120M | Hold |
|
|||||
|
2024
Q3 | $105M | Sell |
|
|||||
|
2024
Q2 | $107M | Buy |
|
|||||
|
2024
Q1 | $66.4M | Sell |
|
|||||
|
2023
Q4 | $83.5M | Sell |
|
|||||
|
2023
Q3 | $71.4M | Buy |
|
|||||
|
2023
Q2 | $75.9M | Hold |
|
|||||
|
2023
Q1 | $64.9M | Buy |
|
|||||
|
2022
Q4 | $54.9M | Buy |
|
|||||
|
2022
Q3 | $39.6M | Sell |
|
|||||
|
2022
Q2 | $76.4M | Sell |
|
|||||
|
2022
Q1 | $93.7M | Buy |
|
|||||
|
2021
Q4 | $65.5M | Hold |
|
|||||
|
2021
Q3 | $46.7M | Buy |
|
|||||
|
2021
Q2 | $42.4M | Hold |
|
|||||
|
2021
Q1 | $35.2M | Buy |
|
|||||
|
2020
Q4 | $28.8M | Buy |
|
|||||
|
2020
Q3 | $12.6M | Buy |
|